Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
Global demand for the breast biopsy devices market is set to display growth at a CAGR of about 5.5% from 2022 to 2032, with an estimated market valuation to be around US$ 2.1 Billion as of 2022. As per Future Market Insights projections, the biopsy needle segment as a product holds a substantial share of about 23.4% of the global market in 2021.
Market Outlook:
Data Points | Market Insights |
---|---|
Market Value 2021 | US$ 2.0 Billion |
Market Value 2022 | US$ 2.1 Billion |
Market Value 2032 | US$ 3.6 Billion |
CAGR 2022 to 2032 | 5.5% |
Market Share of Top 5 Countries | 54.7% |
Key Market Players | Argon Medical Devices, Becton Dickinson and Company., C.R. Bard, Inc. Cook Medical Inc., Devicor Medical Products, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Hologic, Inc. Leica Biosystems, Max Srl Unipersonale, Planmed Oy, Scion Medical Technologies, LLC, and Siemens Healthier. |
Changes in one's way of life, such as behavior, nutritional preferences, and physical activity, might make breast cancer worse. Women who are overweight have higher blood insulin levels. Several cancers, particularly breast cancer, have been linked to elevated insulin levels.
Alcohol use, being overweight, using birth control, taking menopausal hormone therapy, and having breast implants are all lifestyle choices that can result in breast cancer. An increase in life expectancy is the reason that is anticipated to promote the expansion of the breast biopsy devices market.
Furthermore, a sophisticated biopsy strategy may enable radiologists and surgeons to perform breast procedures with greater accuracy, simplicity, and convenience. Large chances are being created for players to enter this industry and take over market space with new technology.
It will thus help the market to further grow, by improving the product offering in the market by the key players during the forecast period from 2022 to 2032.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market for breast biopsy devices expanded at a CAGR of 3.6% over the span of 2012 to 2021.
The market value for breast biopsy devices market holds approximately 50% of the overall US$ 4 Billion global breast cancer diagnostics market in 2021
The growing prevalence of breast cancer will drive the demand for breast biopsy devices shortly. The global burden of breast cancer is increasing owing to the growing population along with the changing lifestyle and excessive consumption of tobacco and alcohol. Breast cancer is a major public health issue in low- and middle-income countries. Besides, factors that also contribute to the existing disease burden are poor quality control, low mammography coverage, insufficient physical and human resources for clinical care, and limited access to diagnosis and treatment
The breast cancer-related mortality rate is high among women worldwide. Breast cancer is a major concern throughout the globe. Increased parity, premenopausal status, and shorter duration of breastfeeding are certainly associated with an increased risk of triple-negative breast cancer.
The risk of breast cancer is directly proportional to age. Considering the large geriatric female population, along with increasing awareness about breast cancer and the importance of early detection of the disease, demand for breast surgery retractors is expected to grow rapidly.
In order to study the asymptomatic population, which has an average cancer risk, particularly for breast cancer, appropriate screening techniques must be used. It is crucial that medical professionals, other healthcare workers, and the general public have a better grasp of the early warning signs and symptoms of cancer. The market will grow faster if healthcare policies in developing nations are improved.
Minimally invasive surgeries are gaining a lot of attention because they are not only clinically safer for the patients but also very cost-effective. They also help enable faster recovery.
These surgeries are less painful and since they involve endoscopic and robotic assistance, the precision of the results increases as well, which has a positive impact on the patient’s quality of life.
The rise in the acceptance of liquid biopsies for achieving early detection of cancer reflects the movement towards less invasive procedures.
Additionally, market participants for breast biopsy devices are concentrating on collaborating with hospitals and ambulatory surgical centers for direct sales and maintenance of the equipment as well as training staff to raise knowledge of cutting-edge technology.
An increase in the funding for cancer research has driven many cancer research institutes and has led to substantial improvements in patient survival rates and dramatic improvements in the quality of life for patients with cancer.
The market is expected to expand at a significant rate over the next ten years at a CAGR close to 5.5% and offers an absolute $ opportunity of US$ 109.3 Million.
The above-mentioned factors are primarily insightful concerning the global sales growth of the breast biopsy devices market and are anticipated to persistently progress market growth over the forecasted period of 2022 to 2032.
Breast Biopsy Devices are becoming more used in the detection and mapping of breast cancer. However, only a few players that are actively engaged in the manufacturing of breast biopsy devices to date, implying that there are significant opportunities for other small and large manufacturers to enter the market, as demand for the devices is rapidly increasing.
Breast cancer is the most common cancer in emerging nations, and it is growing rapidly among women in metropolitan regions. The importance of early detection in the management and treatment of this condition cannot be overstated. As a result, breast cancer awareness activities are organized to raise awareness and eliminate the stigma associated with breast cancer symptoms and treatment.
This increasing incidence rate creates huge opportunities for market players in emerging regions.
A greater patient base with cancer and rising per capita income would also create profitable chances for market penetration and economic expansion across the globe.
The expensive expense of devices, as well as a scarcity of qualified specialists capable of carrying out important and advanced cancer detection processes, are constraints limiting demand for breast biopsy devices. Breast cancer surgeries, such as breast lumpectomy, biopsy, and other procedures, are expensive. The high cost of the equipment, the expense of associated high services, and equipment that are inaccessible to most patients in most countries are major market restraints.
Breast Biopsy Devices are the most advanced method for the detection and removal of cysts. This method requires expertise on the part of the staff and trainees. Many hospitals and healthcare centers lack such skilled professionals to use these devices during diagnosis or surgeries.
Thus, the lack of trained staff and other challenges are expected to hamper the adoption of these devices, which in turn is expected to restrain the market’s growth.
The USA led the North American region with a market share of about 88.6% in the year 2021 and is estimated to show higher growth in this sector, in comparison to Canada, throughout the forecast period. The American Cancer Society's estimate for breast cancer in the USA for 2022 is about 287,850 new cases of invasive breast cancer, which is projected to surge the demand for core needle biopsy devices.
The rise in the prevalence of breast cancer, raising awareness of breast cancer early detection, improving government expenditures on breast cancer research, and increasing usage of devices in cancer centers is the primary factor boosting the USA breast biopsy devices market growth in the region. Because of the total replacement of conventional open surgical biopsy techniques with less invasive alternatives, the USA has turned out to be the largest geographical market for breast biopsy devices.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
United Kingdom is set to exhibit a CAGR of nearly 5.6% in the European breast biopsy devices market during the forecast period. Since the population in the United Kingdom is more conscious of their own health, and cancer screening and diagnosis rates are both high in this country, the market for breast biopsy equipment is expected to expand at a quicker rate there. In addition, the huge population and adult population of the United Kingdom is more susceptible to getting breast cancer as a result of weakened immune systems and changing lifestyles.
Other than that, the market for breast biopsy devices is also getting driven in developed economies such as France, Germany, and Spain by these same factors, consequently surging the sales of breast biopsy devices in Europe. The region's fast-rising countries have invested in infrastructure development for research in the healthcare sector, propelling the breast biopsy devices market growth.
During the projected period, the North American industry is expected to lose considerable market share to the fast-expanding Asia-Pacific market. China is the fastest growing, with a CAGR of 6.4% in the East Asia market during the forecast period. However, in recent years Japan has also emerged to be a growing market for vacuum biopsy needles which is inferred to be a challenge to China’s dominance in the region.
The increased number of breast cancer patients in the country mirrors the country's growing dominance in the biopsy devices market in the Asia Pacific region. Furthermore, the emergence of Japan's breast biopsy devices market is linked to increased reimbursements for the most recent and sophisticated biopsy techniques by the national and regional governments.
The South Korean breast biopsy devices market is being driven by the rapid development of healthcare infrastructure, the increasing replacement of stereotactic X-ray biopsy systems with MRI-guided systems, and the growing number of breast cancer patients. Furthermore, the rapid growth of medical tourism in the region would provide breast biopsy device manufacturers with further market recognition potential.
Breast cancer's growing incidence rate has created critical commercial growth prospects for South Korean breast biopsy device market players. Furthermore, technical developments and breakthroughs in breast biopsy instruments are driving this market to expand in Asia Pacific countries, including South Korea. Unfortunately, the many negative side effects of the procedure, as well as the expensive price, may still restrict the regional market from expanding to its full potential.
The USA leads the North American region with a market share of about 88.6% in 2021 and is estimated to show high growth throughout the forecast period. The rise in the prevalence of breast cancer, raising awareness of breast cancer early detection, improving government expenditures on breast cancer research, and increasing usage of devices in cancer centers in the USA is the major factor boosting the market growth in the region.
The American Cancer Society's estimate for breast cancer in the USA for 2022 is about 287,850 new cases of invasive breast cancer will be diagnosed in women
United Kingdom is set to exhibit a CAGR of nearly 5.6% in the European breast biopsy devices market during the forecast period. Since the population in the United Kingdom is more conscious of their own health and cancer screening and diagnosis rates are both high in this country, the market for breast biopsy equipment is expected to expand at a quicker rate there.
In addition, the huge population and adult population of the United Kingdom is more susceptible to getting breast cancer as a result of weakened immune systems and changing lifestyles. The market for breast biopsy devices is driven by these factors.
China is the fastest growing with a CAGR of 6.4% in the East Asia market during the forecast period. The increased number of breast cancer patients in the country mirrors the country's dominance in the breast biopsy devices market.
Nearly 416 thousand new instances of breast cancer were estimated to have been discovered in Chinese women in 2020, according to statistics.
Biopsy needles segment projects lucrative growth holding a market share of around 23.4% in 2021, owing to its cost-effectiveness, and ease for surgeons and radiologists to use it while surgeries. To identify the origin of an abnormality, a thin, hollowed needle, and syringe are used to collect cells, fluids, or tissues from a suspected mass or another abnormal part of the body. These samples are then inspected under a microscope or evaluated in a lab. A needle biopsy can determine whether a lump or mass is a benign tumor, cyst, infection, or malignancy. The market for breast biopsy devices is being driven by these various considerations.
Complex cyst estimates a lucrative growth opportunity at a CAGR of 6.1% throughout the forecast period of 2022 to 2032 and shows a market share of around 37.2% in 2021. Complex breast cysts are defined as cysts with thick walls, thick septa, intracystic masses, or other discrete solid components. Breast cysts are extremely common and are present in most women over 40 years old. Breast ultrasound allows its detection and the correct diagnosis of cysts has been reported to be almost 100%. This makes the biopsy segment grow with great market space.
Hospitals as end users lead the breast biopsy devices market with about 34.2% market share in 2021. Hospitals have a huge amount of footfall for diagnosis and surgeries of breast cancer also companies are focusing on unique strategies of training surgeons and radiologists in hospitals for more patient reach this is gaining traction.
Key players are focused on the development and launch of novel detection devices for breast cancers. Established players within the industry are targeting specific female groups and going after strategic mergers and acquisitions to strengthen their position in the breast biopsy devices market.
Similarly, recent developments related to companies manufacturing breast biopsy device techniques have been tracked by the team at Future Market Insights, which are available in the full report.
Attribute | Details |
---|---|
Forecast Period | 2022 to 2032 |
Historical Data Available for | 2012 to 2021 |
Market Analysis | US$ Million for Value and Volume in Units |
Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, United Kingdom, France, Italy, Spain, Russia, BENELUX, Nordic countries, Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, GCC Countries, Turkey, and South Africa |
Key Market Segments Covered | Product, Indication, End User, and Region |
Key Companies Profiled |
|
Pricing | Available upon Request |
The global breast biopsy devices market is worth US$ 2.0 Billion in 2021 and is set to expand by 1.7X over the next ten years.
The breast biopsy devices market is expected to reach US$ 3.6 Billion by the end of 2032, with sales revenue expected to register at 5.5% CAGR.
Increasing incidence of breast cancer, growing life expectancy rate, and an increase in the funding for cancer research are some of the key factors driving the demand in the marketplace.
North America holds 32.0% of the global breast biopsy devices market in 2021 with the USA being the leading contributor in the North American region with a market value of about US$ 568.9 Million in 2021.
The breast biopsy devices market in India is likely to grow at a CAGR of 7.4% during the forecast period, with a market share of around 45.6% in 2021 in the South Asian market for breast biopsy devices.
Acquisitions and collaborations by key players, emerging technologies to enhance the market reach, and a shift from invasive to minimally-invasive surgical procedures are some of the key trends being witnessed in this marketplace.
Japan’s market in breast biopsy devices is offering lucrative growth opportunities and is expected to exhibit healthy growth of 5.8% CAGR during the forecast period.
The U.S., Japan, the United Kingdom, Germany, and China are expected to drive demand for breast biopsy devices.
From 2012 to 2021, the market for breast biopsy devices expanded at a CAGR of 3.6%.
Argon Medical Devices, Becton Dickinson and Company. C.R. Bard, Inc. Cook Medical Inc., Devicor Medical Products, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Hologic, Inc. Leica Biosystems, Medax Srl Unipersonale, Planmed Oy, Scion Medical Technologies, LLC, and Siemens Healthineer, are the key exporter of the breast biopsy devices market.
1. Executive Summary | Breast Biopsy Devices Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusion and Exclusion 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Product Adoption / Usage Analysis 4.2. Key Promotional Strategies, by Manufacturers 4.3. Regulatory Scenario 4.4. PESTLE Analysis 4.5. Porter’s Analysis 4.6. New Product Launches 4.7. Technology Assessment 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Rising demand for Breast Biopsy Devices 5.2.2. Cost of Procedures 5.2.3. Adoption Rate 5.2.4. Increase in Research and Development 5.2.5. Availability 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. COVID-19 and Impact Analysis 6.1.1. Revenue By Product 6.1.2. Revenue By Indication 6.1.3. Revenue By End User 6.1.4. Revenue By Country 6.2. 2021 Market Scenario 7. Global Market Demand (in Volume Units) Analysis 2012 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Volume (Units) Analysis, 2012 to 2021 7.2. Current and Future Market Volume (units) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market- Pricing Analysis 8.1. Regional Pricing Analysis by Product 8.2. Pricing Break-up 8.2.1. Manufacturer-Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 8.4. Pricing Assumptions 9. Global Market Demand (in Value US$ Million) Analysis 2012 to 2021 and Forecast, 2022 to 2032 9.1. Historical Market Value (US$ Million) Analysis, 2012 to 2021 9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis & Volume (Units) by Product, 2012 to 2021 10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2022 to 2032 10.3.1. Biopsy Needle 10.3.1.1. Core Needles 10.3.1.2. Fine Aspiration Needles 10.3.2. MRI-Guide Biopsy Systems 10.3.3. Ultrasound Guided Breast Biopsy Systems 10.3.3.1. Two-Dimensional (2-D) Mammographic Ultrasonic Scanning Systems 10.3.3.2. Three-Dimensional (3-D) B-Mode Mammographic Ultrasonic Scanning Systems 10.3.4. Vacuum-Assisted Device (VAD) 10.3.5. Guide Wire (Localization Wire) 10.3.6. Breast Biopsy Marker 10.4. Market Attractiveness Analysis by Product 11. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Indication 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis by Indication, 2012 to 2021 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Indication, 2022 to 2032 11.3.1. Complex Cyst 11.3.2. Solid Mass 11.3.3. Suspicious Solid Mass 11.3.4. Suspicious Micro Calcifications 11.3.5. Suspicious Architectural Distortion 11.4. Market Attractiveness Analysis by Indication 12. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis By End User, 2012 to 2021 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2032 12.3.1. Hospitals 12.3.2. Specialty Clinics 12.3.3. Ambulatory Surgical Centers 12.3.4. Cancer Research Institutes 12.4. Market Attractiveness Analysis By End User 13. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Region, 2012 to 2021 13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Region, 2022 to 2032 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. South Asia 13.3.5. East Asia 13.3.6. Oceania 13.3.7. Middle East & Africa(MEA) 13.4. Market Attractiveness Analysis by Region 14. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2012 to 2021 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032 14.3.1. By Country 14.3.1.1. USA 14.3.1.2. Canada 14.3.2. By Product 14.3.3. By Indication 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Indication 14.4.4. By End User 14.5. Country-Level Analysis & Forecast 14.5.1. USA Market 14.5.1.1. Introduction 14.5.1.2. Market Analysis and Forecast by Market Taxonomy 14.5.1.2.1. By Product 14.5.1.2.2. By Indication 14.5.1.2.3. By End User 14.5.2. Canada Market 14.5.2.1. Introduction 14.5.2.2. Market Analysis and Forecast by Market Taxonomy 14.5.2.2.1. By Product 14.5.2.2.2. By Indication 14.5.2.2.3. By End-User 15. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2012 to 2021 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast recast by Market Taxonomy, 2022 to 2032 15.3.1. By Country 15.3.1.1. Brazil 15.3.1.2. Mexico 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Product 15.3.3. By Indication 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Indication 15.4.4. By End User 15.5. Country-Level Analysis & Forecast 15.5.1. Brazil Market 15.5.1.1. Introduction 15.5.1.2. Market Analysis and Forecast by Market Taxonomy 15.5.1.2.1. By Product 15.5.1.2.2. By Indication 15.5.1.2.3. By End User 15.5.2. Mexico Market 15.5.2.1. Introduction 15.5.2.2. Market Analysis and Forecast by Market Taxonomy 15.5.2.2.1. By Product 15.5.2.2.2. By Indication 15.5.2.2.3. By End User 15.5.3. Argentina Market 15.5.3.1. Introduction 15.5.3.2. Market Analysis and Forecast by Market Taxonomy 15.5.3.2.1. By Product 15.5.3.2.2. By Indication 15.5.3.2.3. By End User 16. Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2021 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. Italy 16.3.1.3. France 16.3.1.4. United Kingdom 16.3.1.5. Spain 16.3.1.6. BENELUX 16.3.1.7. Nordic Countries 16.3.1.8. Russia 16.3.1.9. Rest of Europe 16.3.2. By Product 16.3.3. By Indication 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Indication 16.4.4. By End User 16.5. Country-Level Analysis & Forecast 16.5.1. Germany Market 16.5.1.1. Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Product 16.5.1.2.2. By Indication 16.5.1.2.3. By End User 16.5.2. Italy Market 16.5.2.1. Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Product 16.5.2.2.2. By Indication 16.5.2.2.3. By End User 16.5.3. France Market 16.5.3.1. Introduction 16.5.3.2. Market Analysis and Forecast by Market Taxonomy 16.5.3.2.1. By Product 16.5.3.2.2. By Indication 16.5.3.2.3. By End User 16.5.4. United Kingdom Market 16.5.4.1. Introduction 16.5.4.2. Market Analysis and Forecast by Market Taxonomy 16.5.4.2.1. By Product 16.5.4.2.2. By Indication 16.5.4.2.3. By End User 16.5.5. Spain Market 16.5.5.1. Introduction 16.5.5.2. Market Analysis and Forecast by Market Taxonomy 16.5.5.2.1. By Product 16.5.5.2.2. By Indication 16.5.5.2.3. By End User 16.5.6. BENELUX Market 16.5.6.1. Introduction 16.5.6.2. Market Analysis and Forecast by Market Taxonomy 16.5.6.2.1. By Product 16.5.6.2.2. By Indication 16.5.6.2.3. By End User 16.5.7. Nordic Countries Market 16.5.7.1. Introduction 16.5.7.2. Market Analysis and Forecast by Market Taxonomy 16.5.7.2.1. By Product 16.5.7.2.2. By Indication 16.5.7.2.3. By End User 16.5.8. Russia Market 16.5.8.1. Introduction 16.5.8.2. Market Analysis and Forecast by Market Taxonomy 16.5.8.2.1. By Product 16.5.8.2.2. By Indication 16.5.8.2.3. By End User 17. South Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2021 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Thailand 17.3.1.3. Indonesia 17.3.1.4. Malaysia 17.3.1.5. Rest of South Asia 17.3.2. By Product 17.3.3. By Indication 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Indication 17.4.4. By End User 17.5. Country-Level Analysis & Forecast 17.5.1. India Market 17.5.1.1. Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Product 17.5.1.2.2. By Indication 17.5.1.2.3. By End User 17.5.2. Thailand Market 17.5.2.1. Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Product 17.5.2.2.2. By Indication 17.5.2.2.3. By End User 17.5.3. Indonesia Market 17.5.3.1. Introduction 17.5.3.2. Market Analysis and Forecast by Market Taxonomy 17.5.3.2.1. By Product 17.5.3.2.2. By Indication 17.5.3.2.3. By End User 17.5.4. Malaysia Market 17.5.4.1. Introduction 17.5.4.2. Market Analysis and Forecast by Market Taxonomy 17.5.4.2.1. By Product 17.5.4.2.2. By Indication 17.5.4.2.3. By End User 18. East Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2021 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.2. By Product 18.3.3. By Indication 18.3.4. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Indication 18.4.4. By End User 18.5. Country-Level Analysis & Forecast 18.5.1. China Market 18.5.1.1. Introduction 18.5.1.2. Market Analysis and Forecast by Market Taxonomy 18.5.1.2.1. By Product 18.5.1.2.2. By Indication 18.5.1.2.3. By End User 18.5.2. Japan Market 18.5.2.1. Introduction 18.5.2.2. Market Analysis and Forecast by Market Taxonomy 18.5.2.2.1. By Product 18.5.2.2.2. By Indication 18.5.2.2.3. By End User 18.5.3. South Korea Market 18.5.3.1. Introduction 18.5.3.2. Market Analysis and Forecast by Market Taxonomy 18.5.3.2.1. By Product 18.5.3.2.2. By Indication 18.5.3.2.3. By End User 19. Oceania Market Analysis 2012 to 2021 and Forecast 2022 to 2032 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2021 19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Product 19.3.3. By Indication 19.3.4. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Indication 19.4.4. By End User 19.5. Country-Level Analysis & Forecast 19.5.1. Australia Market 19.5.1.1. Introduction 19.5.1.2. Market Analysis and Forecast by Market Taxonomy 19.5.1.2.1. By Product 19.5.1.2.2. By Indication 19.5.1.2.3. By End User 19.5.2. New Zealand Market 19.5.2.1. Introduction 19.5.2.2. Market Analysis and Forecast by Market Taxonomy 19.5.2.2.1. By Product 19.5.2.2.2. By Indication 19.5.2.2.3. By End User 20. Middle East & Africa Market Analysis 2012 to 2021and Forecast 2022 to 2032 20.1. Introduction 20.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2021 20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. Turkey 20.3.1.3. South Africa 20.3.1.4. Rest of Middle East and Africa(MEA) 20.3.2. By Product 20.3.3. By Indication 20.3.4. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product 20.4.3. By Indication 20.4.4. By End User 20.5. Country-Level Analysis & Forecast 20.5.1. GCC Countries Market 20.5.1.1. Introduction 20.5.1.2. Market Analysis and Forecast by Market Taxonomy 20.5.1.2.1. By Product 20.5.1.2.2. By Indication 20.5.1.2.3. By End User 20.5.2. Turkey Market 20.5.2.1. Introduction 20.5.2.2. Market Analysis and Forecast by Market Taxonomy 20.5.2.2.1. By Product 20.5.2.2.2. By Indication 20.5.2.2.3. By End User 20.5.3. South Africa Market 20.5.3.1. Introduction 20.5.3.2. Market Analysis and Forecast by Market Taxonomy 20.5.3.2.1. By Product 20.5.3.2.2. By Indication 20.5.3.2.3. By End User 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Deep Dive 21.2.1. Argon Medical Devices 21.2.1.1. Overview 21.2.1.2. Product Portfolio 21.2.1.3. Key Financial 21.2.1.4. Sales Footprint 21.2.1.5. SWOT Analysis 21.2.1.6. Strategy Overview 21.2.1.6.1. Marketing Strategies 21.2.1.6.2. Product Strategies 21.2.1.6.3. Channel Strategies 21.2.2. Becton Dickinson and Company 21.2.2.1. Overview 21.2.2.2. Product Portfolio 21.2.2.3. Key Financial 21.2.2.4. Sales Footprint 21.2.2.5. SWOT Analysis 21.2.2.6. Strategy Overview 21.2.2.6.1. Marketing Strategies 21.2.2.6.2. Product Strategies 21.2.2.6.3. Channel Strategies 21.2.3. C. R. Bard, Inc. 21.2.3.1. Overview 21.2.3.2. Product Portfolio 21.2.3.3. Key Financial 21.2.3.4. Sales Footprint 21.2.3.5. SWOT Analysis 21.2.3.6. Strategy Overview 21.2.3.6.1. Marketing Strategies 21.2.3.6.2. Product Strategies 21.2.3.6.3. Channel Strategies 21.2.4. Cook Medical Inc. 21.2.4.1. Overview 21.2.4.2. Product Portfolio 21.2.4.3. Key Financial 21.2.4.4. Sales Footprint 21.2.4.5. SWOT Analysis 21.2.4.6. Strategy Overview 21.2.4.6.1. Marketing Strategies 21.2.4.6.2. Product Strategies 21.2.4.6.3. Channel Strategies 21.2.5. Devicor Medical Products, Inc. 21.2.5.1. Overview 21.2.5.2. Product Portfolio 21.2.5.3. Key Financial 21.2.5.4. Sales Footprint 21.2.5.5. SWOT Analysis 21.2.5.6. Strategy Overview 21.2.5.6.1. Marketing Strategies 21.2.5.6.2. Product Strategies 21.2.5.6.3. Channel Strategies 21.2.6. F. Hoffmann-La Roche Ltd. 21.2.6.1. Overview 21.2.6.2. Product Portfolio 21.2.6.3. Key Financial 21.2.6.4. Sales Footprint 21.2.6.5. SWOT Analysis 21.2.6.6. Strategy Overview 21.2.6.6.1. Marketing Strategies 21.2.6.6.2. Product Strategies 21.2.6.6.3. Channel Strategies 21.2.7. GE Healthcare 21.2.7.1. Overview 21.2.7.2. Product Portfolio 21.2.7.3. Key Financial 21.2.7.4. Sales Footprint 21.2.7.5. SWOT Analysis 21.2.7.6. Strategy Overview 21.2.7.6.1. Marketing Strategies 21.2.7.6.2. Product Strategies 21.2.7.6.3. Channel Strategies 21.2.8. Hologic, Inc. 21.2.8.1. Overview 21.2.8.2. Product Portfolio 21.2.8.3. Key Financial 21.2.8.4. Sales Footprint 21.2.8.5. SWOT Analysis 21.2.8.6. Strategy Overview 21.2.8.6.1. Marketing Strategies 21.2.8.6.2. Product Strategies 21.2.8.6.3. Channel Strategies 21.2.9. Leica Biosystems 21.2.9.1. Overview 21.2.9.2. Product Portfolio 21.2.9.3. Key Financial 21.2.9.4. Sales Footprint 21.2.9.5. SWOT Analysis 21.2.9.6. Strategy Overview 21.2.9.6.1. Marketing Strategies 21.2.9.6.2. Product Strategies 21.2.9.6.3. Channel Strategies 21.2.10. Medax Srl Unipersonale 21.2.10.1. Overview 21.2.10.2. Product Portfolio 21.2.10.3. Key Financial 21.2.10.4. Sales Footprint 21.2.10.5. SWOT Analysis 21.2.10.6. Strategy Overview 21.2.10.6.1. Marketing Strategies 21.2.10.6.2. Product Strategies 21.2.10.6.3. Channel Strategies 21.2.11. Planmed Oy 21.2.11.1. Overview 21.2.11.2. Product Portfolio 21.2.11.3. Key Financial 21.2.11.4. Sales Footprint 21.2.11.5. SWOT Analysis 21.2.11.6. Strategy Overview 21.2.11.6.1. Marketing Strategies 21.2.11.6.2. Product Strategies 21.2.11.6.3. Channel Strategies 21.2.12. Scion Medical Technologies, LLC 21.2.12.1. Overview 21.2.12.2. Product Portfolio 21.2.12.3. Key Financial 21.2.12.4. Sales Footprint 21.2.12.5. SWOT Analysis 21.2.12.6. Strategy Overview 21.2.12.6.1. Marketing Strategies 21.2.12.6.2. Product Strategies 21.2.12.6.3. Channel Strategies 21.2.13. Siemens Healthier 21.2.13.1. Overview 21.2.13.2. Product Portfolio 21.2.13.3. Key Financial 21.2.13.4. Sales Footprint 21.2.13.5. SWOT Analysis 21.2.13.6. Strategy Overview 21.2.13.6.1. Marketing Strategies 21.2.13.6.2. Product Strategies 21.2.13.6.3. Channel Strategies 22. Assumptions and Acronyms Used 23. Research Methodology
Table 01: Global Market Size Volume (Units) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 02: Global Market Size Volume (Units) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 03: Global Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 04: Global Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 05: Global Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Indication Table 06: Global Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Indication Table 07: Global Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User Table 08: Global Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User Table 09: Global Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Region Table 10: Global Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Region Table 11: North America Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Country Table 12: North America Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Country Table 13: North America Market Size Volume (Units) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 14: North America Market Size Volume (Units) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 15: North America Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 16: North America Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 17: North America Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Indication Table 18: North America Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Indication Table 19: North America Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User Table 20: North America Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User Table 21: Latin America Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Country Table 22: Latin America Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Country Table 23: Latin America Market Size Volume (Units) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 24: Latin America Market Size Volume (Units) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 25: Latin America Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 26: Latin America Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 27: Latin America Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Indication Table 28: Latin America Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Indication Table 29: Latin America Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User Table 30: Latin America Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User Table 31: Europe Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Country Table 32: Europe Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Country Table 33: Europe Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 34: Europe Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 35: Europe Market Size Volume (Units) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 36: Europe Market Size Volume (Units) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 37: Europe Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Indication Table 38: Europe Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Indication Table 39: Europe Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User Table 40: Europe Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User Table 41: East Asia Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Country Table 42: East Asia Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Country Table 43: East Asia Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 44: East Asia Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 45: East Asia Market Size Volume (Units) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 46: East Asia Market Size Volume (Units) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 47: East Asia Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Indication Table 48: East Asia Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Indication Table 49: East Asia Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User Table 50: East Asia Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User Table 51: South Asia Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Country Table 52: South Asia Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Country Table 53: South Asia Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 54: South Asia Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 55: South Asia Market Size Volume (Units) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 56: South Asia Market Size Volume (Units) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 57: South Asia Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Indication Table 58: South Asia Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Indication Table 59: South Asia Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User Table 60: South Asia Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User Table 61: Oceania Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Country Table 62: Oceania Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Country Table 63: Oceania Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 64: Oceania Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 65: Oceania Market Size Volume (Units) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 66: Oceania Market Size Volume (Units) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 67: Oceania Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Indication Table 68: Oceania Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Indication Table 69: Oceania Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User Table 70: Oceania Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User Table 71: Middle East and Africa Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Country Table 72: Middle East and Africa Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Country Table 73: Middle East and Africa Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 74: Middle East and Africa Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 75: Middle East and Africa Market Size Volume (Units) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 76: Middle East and Africa Market Size Volume (Units) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product Table 77: Middle East and Africa Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Indication Table 78: Middle East and Africa Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By Indication Table 79: Middle East and Africa Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User Table 80: Middle East and Africa Market Size (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User
Figure 01: Global Market Value Share, By Product 2022 (E) Figure 02: Global Market Value Share, By Indication 2022 (E) Figure 03: Global Market Value Share, By End User 2022 (E) Figure 04: Global Market Value Share, By Region 2022 (E) Figure 05: Global Market Volume (Units) Analysis, 2012 to 2021 Figure 06: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2022 to 2032 Figure 07: Global Average Pricing Analysis Benchmark USD (Unit) (2021) Figure 08: Global Market Size (US$ Million) Analysis, 2012 to 2021 Figure 09: Global Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2022 to 2032 Figure 10: Global Market Absolute $ Opportunity Analysis, 2022 to 2032 Figure 11: Global Market Analysis By Product -2022 & 2032 Figure 12: Global Market Y-o-Y Growth Projections By Product, 2022 to 2032 Figure 13: Global Market Attractiveness, By Product, 2022 to 2032 Figure 14: Global Market Analysis By Indication-2022 and 2032 Figure 15A: Global Market Y-o-Y Growth Projections By Indication, 2022 to 2032 Figure 15B: Global Market Attractiveness, By Indication, 2022 to 2032 Figure 16: Global Market Analysis By End User -2022 and 2032 Figure 17: Global Market Y-o-Y Growth Projections By End User, 2022 to 2032 Figure 18: Global Market Attractiveness, By End User, 2022 to 2032 Figure 19: Global Market Analysis by Region-2022 and 2032 Figure 20: Global Market Y-o-Y Growth Projections by Region, 2022 to 2032 Figure 21: Global Market Attractiveness, By Region, 2022 to 2032 Figure 22: North America Market Value Share, By Product 2022 (E) Figure 23: North America Market Value Share, By Indication 2022 (E) Figure 24: North America Market Value Share, By End User 2022 (E) Figure 25: North America Market Value Share, By Region 2022 (E) Figure 26: North America Market Size (US$ Million) Analysis, 2012 to 2021 Figure 27: North America Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2022 to 2032 Figure 28: North America Market Attractiveness Analysis, By Country Figure 29: North America Market Attractiveness Analysis, By Product Figure 30: North America Market Attractiveness, By Indication Figure 31: North America Market Attractiveness, By End User Figure 32: USA Market Value Proportion Analysis, 2021 Figure 33: Global Vs. USA Growth Comparison, 2021 to 2032 Figure 34: USA Market Share Analysis (%), By Product, 2021 and 2032 Figure 35: USA Market Share Analysis (%), By Indication, 2021 and 2032 Figure 36: USA Market Share Analysis (%), By End User, 2021 and 2032 Figure 37: Canada Market Value Proportion Analysis, 2021 Figure 38: Global Vs. Canada Growth Comparison, 2021 to 2032 Figure 39: Canada Market Share Analysis (%), By Product, 2021 and 2032 Figure 40: Canada Market Share Analysis (%), By Indication, 2021 and 2032 Figure 41: Canada Market Share Analysis (%), By End User, 2021 and 2032 Figure 42: Latin America Market Value Share, By Product 2022 (E) Figure 43: Latin America Market Value Share, By Indication 2022 (E) Figure 44: Latin America Market Value Share, By End User 2022 (E) Figure 45: Latin America Market Value Share, By Region 2022 (E) Figure 46: Latin America Market Size (US$ Million) Analysis, 2012 to 2021 Figure 47: Latin America Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2022 to 2032 Figure 48: Latin America Market Attractiveness Analysis, By Country Figure 49: Latin America Market Attractiveness Analysis, By Product Figure 50: Latin America Market Attractiveness, By Indication Figure 51: Latin America Market Attractiveness, By End User Figure 52: Brazil Market Value Proportion Analysis, 2021 Figure 53: Global Vs. Brazil Growth Comparison, 2021 to 2032 Figure 54: Brazil Market Share Analysis (%), By Product, 2021 and 2032 Figure 55: Brazil Market Share Analysis (%), By Indication, 2021 and 2032 Figure 56: Brazil Market Share Analysis (%), By End User, 2021 and 2032 Figure 57: Mexico Market Value Proportion Analysis, 2021 Figure 58: Global Vs. Mexico Growth Comparison, 2021 to 2032 Figure 59: Mexico Market Share Analysis (%), By Product, 2021 and 2032 Figure 60: Mexico Market Share Analysis (%), By Indication, 2021 and 2032 Figure 61: Mexico Market Share Analysis (%), By End User, 2021 and 2032 Figure 62: Argentina Market Value Proportion Analysis, 2021 Figure 63: Global Vs. Argentina Growth Comparison, 2021 to 2032 Figure 64: Argentina Market Share Analysis (%), By Product, 2021 and 2032 Figure 65: Argentina Market Share Analysis (%), By Indication, 2021 and 2032 Figure 66: Argentina Market Share Analysis (%), By End User, 2021 and 2032 Figure 67: Europe Market Value Share, By Product 2022 (E) Figure 68: Europe Market Value Share, By Indication 2022 (E) Figure 69: Europe Market Value Share, By End User 2022 (E) Figure 70: Europe Market Value Share, By Region 2022 (E) Figure 71: Europe Market Size (US$ Million) Analysis, 2012 to 2021 Figure 72: Europe Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2022 to 2032 Figure 73: Europe Market Attractiveness Analysis, By Country Figure 74: Europe Market Attractiveness Analysis, By Product Figure 75: Europe Market Attractiveness, By Indication Figure 76: Europe Market Attractiveness, By End User Figure 77: United Kingdom Market Value Proportion Analysis, 2021 Figure 78: Global Vs.United Kingdom Growth Comparison, 2021 to 2032 Figure 79: United Kingdom Market Share Analysis (%), By Product, 2021 and 2032 Figure 80: United Kingdom Market Share Analysis (%), By Indication, 2021 and 2032 Figure 81: United Kingdom Market Share Analysis (%), By End User, 2021 and 2032 Figure 82: Germany Market Value Proportion Analysis, 2021 Figure 83: Global Vs. Germany Growth Comparison, 2021 to 2032 Figure 84: Germany Market Share Analysis (%), By Product, 2021 and 2032 Figure 85: Germany Market Share Analysis (%), By Indication, 2021 and 2032 Figure 86: Germany Market Share Analysis (%), By End User, 2021 and 2032 Figure 87: Italy Market Value Proportion Analysis, 2021 Figure 88: Global Vs. Italy Growth Comparison, 2021 to 2032 Figure 89: Italy Market Share Analysis (%), By Product, 2021 and 2032 Figure 90: Italy Market Share Analysis (%), By Indication, 2021 and 2032 Figure 91: Italy Market Share Analysis (%), By End User, 2021 and 2032 Figure 92: France Market Value Proportion Analysis, 2021 Figure 93: Global Vs. France Growth Comparison, 2021 to 2032 Figure 94: France Market Share Analysis (%), By Product, 2021 and 2032 Figure 95: France Market Share Analysis (%), By Indication, 2021 and 2032 Figure 96: France Market Share Analysis (%), By End User, 2021 and 2032 Figure 97: Spain Market Value Proportion Analysis, 2021 Figure 98: Global Vs. Spain Growth Comparison, 2021 to 2032 Figure 99: Spain Market Share Analysis (%), By Product, 2021 and 2032 Figure 100: Spain Market Share Analysis (%), By Indication, 2021 and 2032 Figure 101: Spain Market Share Analysis (%), By End User, 2021 and 2032 Figure 102: BENELUX Market Value Proportion Analysis, 2021 Figure 103: Global Vs. BENELUX Growth Comparison, 2021 to 2032 Figure 104: BENELUX Market Share Analysis (%), By Product, 2021 and 2032 Figure 105: BENELUX Market Share Analysis (%), By Indication, 2021 and 2032 Figure 106: BENELUX Market Share Analysis (%), By End User, 2021 and 2032 Figure 107: Nordic Countries Market Value Proportion Analysis, 2021 Figure 108: Global Vs. Nordic Countries Growth Comparison, 2021 to 2032 Figure 109: Nordic Countries Market Share Analysis (%), By Product, 2021 and 2032 Figure 110: Nordic Countries Market Share Analysis (%), By Indication, 2021 and 2032 Figure 111: Nordic Countries Market Share Analysis (%), By End User, 2021 and 2032 Figure 112: Russia Market Value Proportion Analysis, 2021 Figure 113: Global Vs. Russia Growth Comparison, 2021 to 2032 Figure 114: Russia Market Share Analysis (%), By Product, 2021 and 2032 Figure 115: Russia Market Share Analysis (%), By Indication, 2021 and 2032 Figure 116: Russia Market Share Analysis (%), By End User, 2021 and 2032 Figure 117: East Asia Market Value Share, By Product 2022 (E) Figure 118: East Asia Market Value Share, By Indication 2022 (E) Figure 119: East Asia Market Value Share, By End User 2022 (E) Figure 120: East Asia Market Value Share, By Region 2022 (E) Figure 121: East Asia Market Size (US$ Million) Analysis, 2012 to 2021 Figure 122: East Asia Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2022 to 2032 Figure 123: East Asia Market Attractiveness Analysis, By Country Figure 124: East Asia Market Attractiveness Analysis, By Product Figure 125: East Asia Market Attractiveness, By Indication Figure 126: East Asia Market Attractiveness, By End User Figure 127: China Market Value Proportion Analysis, 2021 Figure 128: Global Vs. China Growth Comparison, 2021 to 2032 Figure 129: China Market Share Analysis (%), By Product, 2021 and 2032 Figure 130: China Market Share Analysis (%), By Indication, 2021 and 2032 Figure 131: China Market Share Analysis (%), By End User, 2021 and 2032 Figure 132: Japan Market Value Proportion Analysis, 2021 Figure 133: Global Vs. Japan Growth Comparison, 2021 to 2032 Figure 134: Japan Market Share Analysis (%), By Product, 2021 and 2032 Figure 135: Japan Market Share Analysis (%), By Indication, 2021 and 2032 Figure 136: Japan Market Share Analysis (%), By End User, 2021 and 2032 Figure 137: South Korea Market Value Proportion Analysis, 2021 Figure 138: Global Vs. South Korea Growth Comparison, 2021 to 2032 Figure 139: South Korea Market Share Analysis (%), By Product, 2021 and 2032 Figure 140: South Korea Market Share Analysis (%), By Indication, 2021 and 2032 Figure 141: South Korea Market Share Analysis (%), By End User, 2021 and 2032 Figure 142: South Asia Market Value Share, By Product 2022 (E) Figure 143: South Asia Market Value Share, By Indication 2022 (E) Figure 144: South Asia Market Value Share, By End User 2022 (E) Figure 145: South Asia Market Value Share, By Region 2022 (E) Figure 146: South Asia Market Size (US$ Million) Analysis, 2012 to 2021 Figure 147: South Asia Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2022 to 2032 Figure 148: South Asia Market Attractiveness Analysis, By Country Figure 149: South Asia Market Attractiveness Analysis, By Product Figure 150: South Asia Market Attractiveness, By Indication Figure 151: South Asia Market Attractiveness, By End User Figure 152: India Market Value Proportion Analysis, 2021 Figure 153: Global Vs. India Growth Comparison, 2021 to 2032 Figure 154: India Market Share Analysis (%), By Product, 2021 and 2032 Figure 155: India Market Share Analysis (%), By Indication, 2021 and 2032 Figure 156: India Market Share Analysis (%), By End User, 2021 and 2032 Figure 157: Malaysia Market Value Proportion Analysis, 2021 Figure 158: Global Vs. Malaysia Growth Comparison, 2021 to 2032 Figure 159: Malaysia Market Share Analysis (%), By Product, 2021 and 2032 Figure 160: Malaysia Market Share Analysis (%), By Indication, 2021 and 2032 Figure 161: Malaysia Market Share Analysis (%), By End User, 2021 and 2032 Figure 162: Indonesia Market Value Proportion Analysis, 2021 Figure 163: Global Vs. Indonesia Growth Comparison, 2021 to 2032 Figure 164: Indonesia Market Share Analysis (%), By Product, 2021 and 2032 Figure 165: Indonesia Market Share Analysis (%), By Indication, 2021 and 2032 Figure 166: Indonesia Market Share Analysis (%), By End User, 2021 and 2032 Figure 167: Thailand Market Value Proportion Analysis, 2021 Figure 168: Global Vs. Thailand Growth Comparison, 2021 to 2032 Figure 169: Thailand Market Share Analysis (%), By Product, 2021 and 2032 Figure 170: Thailand Market Share Analysis (%), By Indication, 2021 and 2032 Figure 171: Thailand Market Share Analysis (%), By End User, 2021 and 2032 Figure 172: Oceania Market Value Share, By Product 2022 (E) Figure 173: Oceania Market Value Share, By Indication 2022 (E) Figure 174: Oceania Market Value Share, By End User 2022 (E) Figure 175: Oceania Market Value Share, By Region 2022 (E) Figure 176: Oceania Market Size (US$ Million) Analysis, 2012 to 2021 Figure 177: Oceania Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2022 to 2032 Figure 178: Oceania Market Attractiveness Analysis, By Country Figure 179: Oceania Market Attractiveness Analysis, By Product Figure 180: Oceania Market Attractiveness, By Indication Figure 181: Oceania Market Attractiveness, By End User Figure 182: Australia Market Value Proportion Analysis, 2021 Figure 183: Global Vs. Australia Growth Comparison, 2021 to 2032 Figure 184: Australia Market Share Analysis (%), By Product, 2021 and 2032 Figure 185: Australia Market Share Analysis (%), By Indication, 2021 and 2032 Figure 186: Australia Market Share Analysis (%), By End User, 2021 and 2032 Figure 187: New Zealand Market Value Proportion Analysis, 2021 Figure 188: Global Vs. New Zealand Growth Comparison, 2021 to 2032 Figure 189: New Zealand Market Share Analysis (%), By Product, 2021 and 2032 Figure 190: New Zealand Market Share Analysis (%), By Indication, 2021 and 2032 Figure 191: New Zealand Market Share Analysis (%), By End User, 2021 and 2032 Figure 192: Middle East and Africa Market Value Share, By Product 2022 (E) Figure 193: Middle East and Africa Market Value Share, By Indication 2022 (E) Figure 194: Middle East and Africa Market Value Share, By End User 2022 (E) Figure 195: Middle East and Africa Market Value Share, By Region 2022 (E) Figure 196: Middle East and Africa Market Size (US$ Million) Analysis, 2012 to 2021 Figure 197: Middle East and Africa Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2022 to 2032 Figure 198: Middle East and Africa Market Attractiveness Analysis, By Country Figure 199: Middle East and Africa Market Attractiveness Analysis, By Product Figure 200: Middle East and Africa Market Attractiveness, By Indication Figure 201: Middle East and Africa Market Attractiveness, By End User Figure 202: GCC Countries Market Value Proportion Analysis, 2021 Figure 203: Global Vs. GCC Countries Growth Comparison, 2021 to 2032 Figure 204: GCC Countries Market Share Analysis (%), By Product, 2021 and 2032 Figure 205: GCC Countries Market Share Analysis (%), By Indication, 2021 and 2032 Figure 206: GCC Countries Market Share Analysis (%), By End User, 2021 and 2032 Figure 207: Turkey Market Value Proportion Analysis, 2021 Figure 208: Global Vs. Turkey Growth Comparison, 2021 to 2032 Figure 209: Turkey Market Share Analysis (%), By Product, 2021 and 2032 Figure 210: Turkey Market Share Analysis (%), By Indication, 2021 and 2032 Figure 211: Turkey Market Share Analysis (%), By End User, 2021 and 2032 Figure 212: South Africa Market Value Proportion Analysis, 2021 Figure 213: Global Vs. South Africa Growth Comparison, 2021 to 2032 Figure 214: South Africa Market Share Analysis (%), By Product, 2021 and 2032 Figure 215: South Africa Market Share Analysis (%), By Indication, 2021 and 2032 Figure 216: South Africa Market Share Analysis (%), By End User, 2021 and 2032
Recommendations
Explore Healthcare Insights
View Reports